Diabetes, once considered a disease of the pancreas, is now understood to be a complex, multi-hormonal disease leading to devastating clinical & financial outcomes. Twenty years of attending A.D.A. scientific congress provides a unique, historical … Read More
Boehringer Ingelheim & Eli Lilly and Evoke Health for Jardiance Jardiance Asks: Consumer Campaign An authentic approach successfully engaged type 2 diabetes patients who were unaware of and unreceptive to learning about the link … Read More
Teva Migraine Drug Ajovy Wins FDA Approval Teva Pharmaceutical Industries Ltd. won U.S. regulatory approval to sell a new treatment for migraines, a key part of the company’s turnaround strategy. The U.S. Food and … Read More
Abilify, Otsuka’s Dose-tracking Digital Pill Deal With Magellan Get ready for the first “smart pill” to make its way to medicine cabinets. Otsuka’s Abilify MyCite, the only FDA-approved digital pill, just took another step … Read More
Echosens & Health Systems Link Up To Build Real-World Evidence Model For NASH Care Diagnostic device maker Echosens is teaming up with the NASH Network and the Kinetix Group to develop a real-world evidence … Read More
Vault Bioventures was privileged to attend the launch celebration for Lumitron Technologies, Inc. New Technology has potential to transform industrial, medical and therapeutic applications. Lumitron HyperVIEW x-ray systems are to be commercialized and manufactured in … Read More
A complicated new clinical trial could give some hope to Alzheimer’s patients and investors in drug companies. But there are lots of devilish details. Drugmakers Biogen and Eisai said the top dose of an experimental … Read More
